Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q2 2025 · 10-Q
Revenue$9.22M$9.22M+17.3% vs Q2 2024 Net Income-$5.84M-$5.84MN/M vs Q2 2024 EPS Diluted-$0.21-$0.21N/M vs Q2 2024 Gross Profit$5,556,000+11.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,552,000N/M Free Cash Flowderived-$2,643,000N/M Margins · derivedGross margin60.3%−3.2 pt vs Q2 2024
Operating margin-61.6%−1.5 pt vs Q2 2024
Net margin-63.3%−7.2 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 12, 2025 · 43 d after period end